Literature DB >> 14980537

The development of antimicrobials and vaccines against bacterial bioterrorism agents--where are we?

Peter H Gilligan.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14980537     DOI： 10.1016/S1359-6446(03)03002-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  2 in total

1.  A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.

Authors:  Gaobing Wu; Yuzhi Hong; Aizhen Guo; Chunfang Feng; Sha Cao; Cheng-Cai Zhang; Ruiping Shi; Yadi Tan; Ziduo Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

2.  Evaluation of immune response to recombinant Bacillus anthracis LFD1-PA4 chimeric protein.

Authors:  H Mirhaj; H Honari; E Zamani
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.